Supreme Court to decide on Rx data-mining case

The Supreme Court will take a closer look at whether states should be allowed to ban the sale of doctors' prescription data to drug companies, the Wall Street Journal reports. The ruling would affect how pharma companies hone their marketing. Some data companies such as IMS Health Inc. collect information from pharmacies on which drugs physicians prescribe and how often. Drug makers buy the data to craft marketing pitches and see which salespeople perform best. Vermont is one state that has banned the practice, saying data-mining companies may not sell the Rx information for marketing purposes and drug makers may not use it unless the prescribing doctors approves. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.